Aurobindo Pharma share price down 0.62 per cent

The scrip has declined 45.48 per cent in the last one year till date, while the 30-share index has slipped -1.15 per cent during the same period.

The stock’s 52-week high price stood at Rs 1012.9 and the 52-week low price at Rs 503.4.

Trading volume on the counter stood at 30,453 shares, while it quoted a price-to-earnings ratio of 11.39, an EPS value of 45.2 and a price-to-book value of 1.59. In the Nifty50 pack, 40 stocks traded in the green, while 10 stocks were in the red.

Promoter/FII Holding
Promoters held 51.83 per cent stake in the company as of 31-Mar-2022, while FII and MF ownership stood at 22.48 per cent and 10.09 per cent, respectively.

Key Financials
For the quarter ended 31-Mar-2022, the company reported consolidated sales of Rs 5858.25 crore, down 3.44 per cent from the previous quarter’s Rs 6067.21 crore and down 3.64 per cent from the year-ago quarter’s Rs 6079.6 crore. The company reported net profit of Rs 576.46 crore for the latest quarter.

Technical Indicators

The MACD signalled a bullish bias on the counter. The MACD is known for signalling trend reversals in traded securities or indices. It is the difference between the 26-day and 12-day exponential moving averages. A nine-day exponential moving average, called the signal line, is plotted on top of the MACD to reflect “buy” or “sell” opportunities. When the MACD crosses below the signal line, it gives a bearish signal, indicating that the price of the security may see a downward movement and vice versa.